| Date Filed | Type | Description |
| 06/28/2023 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 16,621 shares
@ $21.6544, valued at
$359.9k
Sold 1,363 shares
@ $22.5349, valued at
$30.7k
|
|
| 02/14/2023 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 48,125 shares
@ $0
Granted 25,739 shares
@ $0
Paid exercise price by delivering 16,291 shares
@ $26.75, valued at
$435.8k
Paid exercise price by delivering 7,755 shares
@ $26.75, valued at
$207.4k
Sold 21,811 shares
@ $26.88, valued at
$586.3k
|
|
| 09/16/2022 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 38,589 shares
@ $18.07, valued at
$697.3k
|
|
| 08/15/2022 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 300 shares
@ $20.01, valued at
$6k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 56,700 shares
@ $0
Granted 14,341 shares
@ $0
Paid exercise price by delivering 6,967 shares
@ $17.63, valued at
$122.8k
Paid exercise price by delivering 4,212 shares
@ $17.63, valued at
$74.3k
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 2,163 shares
@ $25.95, valued at
$56.1k
Paid exercise price by delivering 3,695 shares
@ $25.95, valued at
$95.9k
|
|
| 01/22/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Sold 7,060 shares
@ $20.82, valued at
$147k
|
|
| 09/18/2020 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 734 shares
@ $19.33, valued at
$14.2k
|
|
| 03/18/2020 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 734 shares
@ $15.41, valued at
$11.3k
|
|
| 02/12/2020 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 2,085 shares
@ $21.62, valued at
$45.1k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2019 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Paid exercise price by delivering 1,470 shares
@ $16.98, valued at
$25k
|
|
| 01/29/2019 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 25,600 shares
@ $0
Granted 25,600 options to buy
@ $15.9, valued at
$407k
|
|
| 04/05/2018 |
4
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $24.03, valued at
$961.2k
|
|
| 03/26/2018 |
3
| Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 3 on COLLEGIUM PHARMACEUTICAL, INC |